| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Departments of Surgery [C-N. C., J-T. L., P-H. L., R-H. Y., S-M. W., K-J. C.], Pathology [Y-M. C.], and Medical Ultrasound [F-J. H., M-F. C.], National Taiwan University Hospital, Taipei 100, Taiwan, Republic of China
The purpose of this study was to investigate the clinical usefulness of
the color Doppler vascularity index (CDVI) in patients with colon
cancer before surgery. Forty-four patients with sonographically visible
tumor mass of colon cancer were investigated. The CDVI of each tumor
was determined using transabdominal color Doppler ultrasound. The CDVI
was defined as the ratio of the number of the colored pixels within a
tumor section to the number of total pixels in that specific tumor
section and was calculated by using Encomate software (Electronic
Business Machine Co. Ltd., Taipei, Taiwan). The correlation between the
CDVI and clinicopathological factors, mode of recurrence, and patient
survival was studied. For comparison, microvessel density (the mean
number of microvessels in three areas of highest vascular density at
x200 magnification) of the tumors of these 44 patients was also
evaluated by using immunohistochemical staining of surgical specimens
with anti-CD34. The microvessel density was not correlated with Dukes
classification, clinicopathological factors, and survival. The CDVI was
significantly higher in the patients with lymph node metastases and
vascular invasion than in those without such metastases and invasion
(P = 0.006 and P = 0.0098, respectively). Moreover, in patients with a high CDVI
(>15%) and positive vascular invasion, survival was significantly
poorer than in those with low CDVI (
15%) and negative invasion
(P = 0.0037 and 0.0039, respectively).
Multivariate analysis indicated that liver metastasis, vascular
invasion, and CDVI are independent prognostic factors in the patients
with colon cancer. According to the mode of recurrence in 36 patients
who underwent curative resection, the frequency of the distant organ
recurrence was significantly higher in the high CDVI group (40%) than
in the low CDVI group (0%). The CDVI is a good preoperative indicator
of recurrence and patient survival in colon cancer. Thus, the CDVI may
be helpful in stratifying patients for adjuvant therapy.
This article has been cited by other articles:
![]() |
C. Hsu, C.-N. Chen, L.-T. Chen, C.-Y. Wu, F.-J. Hsieh, and A.-L. Cheng Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogenic Factors Radiology, May 1, 2005; 235(2): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Agarwal, S. Strickland, I. A. McNeish, D. C. Patel, M. Foskett, J. E. Boultbee, E. S. Newlands, and M. J. Seckl Doppler Ultrasonography of the Uterine Artery and the Response to Chemotherapy in Patients with Gestational Trophoblastic Tumors Clin. Cancer Res., May 1, 2002; 8(5): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |